ZHONGSHENG HLDG (00881) spent approximately 7.9388 million Hong Kong dollars on repurchasing 889,000 shares on September 16th.

20:12 16/09/2024

Zhongsheng Holdings (00881) announced that it will repurchase approximately HK$7.9388 million worth of shares on September 16, 2024.

ZHONGSHENG HLDG (00881) announced that on September 16, 2024, it will spend approximately 7.9388 million Hong Kong dollars to repurchase 889,000 shares at a repurchase price of 8.8-9.02 Hong Kong dollars per share.

Jiangsu Hualan New Pharmaceutical Material (301093.SZ) plans to invest 450 million yuan to increase its stake in Lingqing Technology to enhance its strategic layout in the AI pharmaceutical field.

Guotai Haitong: Retail and self-operated business drive securities performance to a high annual growth Recommend Huatai (601688.SH) and CICC (03908).

HAITONG INT'L: First coverage of TSUGAMI CHINA (01651) with an "outperform" rating and target price of HKD 46.94.

Jiangsu Hualan New Pharmaceutical Material (301093.SZ) plans to invest 450 million yuan to increase its stake in Lingqing Technology to enhance its strategic layout in the AI pharmaceutical field.

Guotai Haitong: Retail and self-operated business drive securities performance to a high annual growth Recommend Huatai (601688.SH) and CICC (03908).

HAITONG INT'L: First coverage of TSUGAMI CHINA (01651) with an "outperform" rating and target price of HKD 46.94.